American Portfolios Advisors Alkermes Plc. Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Alkermes Plc. stock. As of the latest transaction made, American Portfolios Advisors holds 1,600 shares of ALKS stock, worth $44,784. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,600Holding current value
$44,784% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding ALKS
# of Institutions
346Shares Held
183MCall Options Held
209KPut Options Held
89.4K-
Black Rock Inc. New York, NY29.1MShares$815 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$560 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.4MShares$402 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$308 Million0.03% of portfolio
-
State Street Corp Boston, MA9.22MShares$258 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.6B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...